Duopharma Biotech Bhd (7148) — Financial Flexibility Index
Duopharma Biotech Bhd (7148) has a Financial Flexibility Index of 0.05x as of December 2025. Free cash flow of RM35.13 Million (operating CF RM30.27 Million minus capex RM4.86 Million) represents 0% of total liabilities (RM690.68 Million). Also explore 7148 year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Duopharma Biotech Bhd Financial Flexibility Index (2006–2025)
Historical Financial Flexibility Index trend for Duopharma Biotech Bhd across 20 annual periods. Check 7148 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Duopharma Biotech Bhd (2006–2025)
Year-by-year free cash flow to debt coverage for Duopharma Biotech Bhd. For the full company profile including market capitalisation, see 7148 stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (MYR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.20x | RM139.46 Million | RM112.71 Million | RM690.68 Million | ▲ +17.4% |
| 2024 | 0.17x | RM114.89 Million | RM82.16 Million | RM667.85 Million | ▲ +24.2% |
| 2023 | 0.14x | RM91.11 Million | RM51.55 Million | RM658.01 Million | ▼ -44.5% |
| 2022 | 0.25x | RM141.29 Million | RM70.27 Million | RM566.70 Million | ▼ -14.9% |
| 2021 | 0.29x | RM158.21 Million | RM43.20 Million | RM540.13 Million | ▼ -11.3% |
| 2020 | 0.33x | RM136.96 Million | RM71.35 Million | RM414.61 Million | ▲ +0.8% |
| 2019 | 0.33x | RM127.84 Million | RM66.96 Million | RM390.05 Million | ▼ -29.4% |
| 2018 | 0.46x | RM165.08 Million | RM72.33 Million | RM355.34 Million | ▼ -19.9% |
| 2017 | 0.58x | RM130.64 Million | RM56.05 Million | RM225.38 Million | ▲ +76.6% |
| 2016 | 0.33x | RM67.92 Million | RM33.24 Million | RM206.95 Million | ▲ +737.5% |
| 2015 | -0.05x | RM-9.46 Million | RM-50.88 Million | RM183.73 Million | ▼ -103.1% |
| 2014 | 1.68x | RM48.40 Million | RM35.97 Million | RM28.85 Million | ▼ -20.2% |
| 2013 | 2.10x | RM48.37 Million | RM39.53 Million | RM23.00 Million | ▲ +18.5% |
| 2012 | 1.77x | RM48.84 Million | RM38.49 Million | RM27.53 Million | ▲ +119.1% |
| 2011 | 0.81x | RM26.79 Million | RM19.37 Million | RM33.08 Million | ▼ -52.6% |
| 2010 | 1.71x | RM65.94 Million | RM40.04 Million | RM38.61 Million | ▲ +1.0% |
| 2009 | 1.69x | RM51.77 Million | RM27.20 Million | RM30.63 Million | ▲ +0.5% |
| 2008 | 1.68x | RM33.34 Million | RM26.46 Million | RM19.83 Million | ▼ -34.3% |
| 2007 | 2.56x | RM33.60 Million | RM25.10 Million | RM13.12 Million | ▲ +9.9% |
| 2006 | 2.33x | RM31.64 Million | RM27.04 Million | RM13.58 Million | — |